|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Department of Psychiatry and Biobehavioral Sciences, University of California - Los Angeles, David Geffen School of Medicine, Los Angeles, CA, USA
* To whom correspondence should be addressed. E-mail: ccolwell{at}mednet.ucla.edu.
Previous studies indicate that light information reaches the suprachiasmatic nucleus (SCN)through a subpopulation of retinal ganglion cells that contain both glutamate and pituitary adenylyl cyclase activating peptide (PACAP). While the role of glutamate in this pathway has been well studied, the involvement of PACAP and its receptors are only beginning to be understood. In order to investigate the functions of PACAP in vivo, we developed a mouse model in which the gene coding for PACAP was disrupted by targeted homologous recombination. Radioimmunoassay was used to confirm a lack of detectable PACAP protein in these mice. PACAP-deficient mice exhibited significant impairment in the magnitude of the response to brief light exposures with both light-induced phase delays and advances of the circadian system impacted. This mutation equally impacted phase shifts induced by bright and dim light exposure. Despite these effects on phase shifting, the loss of PACAP had only limited effects on the generation of circadian oscillations as measured by rhythms in wheel-running activity. Unlike melanopsin-deficient mice, the mice lacking PACAP exhibited no loss of function in the direct lightinduced inhibition of locomotor activity i.e. masking. Finally, the PACAP-deficient mice exhibited normal phase shifts in response to exposure to discrete dark treatments. The results reported here show that the loss of PACAP produced selective deficits in the light response of the circadian system.
This article has been cited by other articles:
![]() |
D. Vaudry, A. Falluel-Morel, S. Bourgault, M. Basille, D. Burel, O. Wurtz, A. Fournier, B. K. C. Chow, H. Hashimoto, L. Galas, et al. Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery Pharmacol. Rev., September 1, 2009; 61(3): 283 - 357. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Beaule, J. W. Mitchell, P. T. Lindberg, R. Damadzic, L. E. Eiden, and M. U. Gillette Temporally restricted role of retinal PACAP: integration of the phase-advancing light signal to the SCN. J Biol Rhythms, April 1, 2009; 24(2): 126 - 134. [Abstract] [PDF] |
||||
![]() |
L. Marpegan, T. J. Krall, and E. D. Herzog Vasoactive Intestinal Polypeptide Entrains Circadian Rhythms in Astrocytes J Biol Rhythms, April 1, 2009; 24(2): 135 - 143. [Abstract] [PDF] |
||||
![]() |
Y.-V. Tan, C. Abad, R. Lopez, H. Dong, S. Liu, A. Lee, R. P. Gomariz, J. Leceta, and J. A. Waschek Pituitary adenylyl cyclase-activating polypeptide is an intrinsic regulator of Treg abundance and protects against experimental autoimmune encephalomyelitis PNAS, February 10, 2009; 106(6): 2012 - 2017. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hannibal, P. Brabet, and J. Fahrenkrug Mice lacking the PACAP type I receptor have impaired photic entrainment and negative masking Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2008; 295(6): R2050 - R2058. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hautmann, U. G. Friis, M. Desch, V. Todorov, H. Castrop, F. Segerer, C. Otto, G. Schutz, and F. Schweda Pituitary Adenylate Cyclase-Activating Polypeptide Stimulates Renin Secretion via Activation of PAC1 Receptors J. Am. Soc. Nephrol., April 1, 2007; 18(4): 1150 - 1156. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Brown, C. S. Colwell, J. A. Waschek, and H. D. Piggins Disrupted Neuronal Activity Rhythms in the Suprachiasmatic Nuclei of Vasoactive Intestinal Polypeptide-Deficient Mice J Neurophysiol, March 1, 2007; 97(3): 2553 - 2558. [Abstract] [Full Text] [PDF] |
||||
![]() |
H.-Y. M. Cheng, H. Dziema, J. Papp, D. P. Mathur, M. Koletar, M. R. Ralph, J. M. Penninger, and K. Obrietan The Molecular Gatekeeper Dexras1 Sculpts the Photic Responsiveness of the Mammalian Circadian Clock J. Neurosci., December 13, 2006; 26(50): 12984 - 12995. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tanaka, N. Shintani, H. Hashimoto, N. Kawagishi, Y. Ago, T. Matsuda, R. Hashimoto, H. Kunugi, A. Yamamoto, C. Kawaguchi, et al. Psychostimulant-induced attenuation of hyperactivity and prepulse inhibition deficits in Adcyap1-deficient mice. J. Neurosci., May 10, 2006; 26(19): 5091 - 5097. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Lacombe, V. Lelievre, C. E. Roselli, W. Salameh, Y.-h. Lue, G. Lawson, J.-M. Muller, J. A. Waschek, and E. Vilain Delayed testicular aging in pituitary adenylate cyclase-activating peptide (PACAP) null mice PNAS, March 7, 2006; 103(10): 3793 - 3798. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Q. Butcher, B. Lee, H.-Y. M. Cheng, and K. Obrietan Light Stimulates MSK1 Activation in the Suprachiasmatic Nucleus via a PACAP-ERK/MAP Kinase-Dependent Mechanism J. Neurosci., June 1, 2005; 25(22): 5305 - 5313. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Levi PACAP enlightenment of mouse circadian clock Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2004; 287(5): R1033 - R1034. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |